HARVARD BIOSCIENCE INC — Director's Dealing 2019

Jul 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2019-07-07

Reporting Person: Duchemin Jeffrey (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-07	Common Stock	D	285473	$0.00	Disposed	464528	Direct

Footnotes

F1: The following restricted stock units were forfeited as a result of the Reporting Person's separation of service from the Issuer effective as of July 7, 2019: (a) 89,402 restricted stock units granted to the Reporting Person on May 25, 2017; (b) 47,222 restricted stock units granted to the Reporting Person on May 24, 2018; (c) 7,556 restricted stock units granted to the Reporting Person on May 24, 2018 that related to an award with a performance condition tied to relative total shareholder return; (d) 84,776 restricted stock units granted to the Reporting Person on March 7, 2019; and (e) restricted stock units, with a target amount of 56,517, granted to the Reporting Person on March 7, 2019 contingent upon achievement of a performance condition tied to relative total shareholder return.